No Data
No Data
Cinda Securities released a research report on April 28 stating that it gave Pumen Technology (688389.SH) a buying rating. The main reasons for the rating include: 1) the company released its quarterly report for the year 24; 2) Specifically, domestic mar
Cinda Securities released a research report on April 28 stating that it gave Pumen Technology (688389.SH) a buying rating. The main reasons for the rating include: 1) the company released its quarterly report for the year 24; 2) Specifically, domestic market revenue was 229 million yuan/yoy +3.67%, accounting for 75%; international market revenue was 77 million yuan/yoy +34.73%, accounting for 25%; 3) the share of high-value-added businesses such as medicine and aesthetics is expected to continue to increase in the future. (Mainichi Keizai Shimbun)
Pumen Technology (688389): Performance is in line with expectations, rapid growth in the international market and IVD
Guide to this report: Steady growth under a high base, 24Q1 performance is in line with expectations. The company continues to deepen management changes and multi-market multi-business platform-based layout, and the performance is expected to continue to grow steadily. Maintain an increase in holdings rating. Key investment points: Maintaining the assessment of increasing holdings
Pumen Technology (688389): Net profit to mother increased 21.69% year-on-year, and the medical and aesthetic business accelerated development
The company published its quarterly report for '24. 24Q1 achieved revenue of 306 million yuan/yoy +10.06%, net profit attributable to mother of 107 million yuan/yoy +21.69%, net profit of non-return to mother of 103 million yuan
Commentary on the 2024 Quarterly Report of Pumen Technology (688389): Performance is in line with expectations, rapid growth in the international market and IVD
Guide to this report: Steady growth under a high base, 24Q1 performance is in line with expectations. The company continues to deepen management changes and multi-market multi-business platform-based layout, and the performance is expected to continue to grow steadily. Maintain an increase in holdings rating. Key investment points: Maintaining the assessment of increasing holdings
Pumen Technology (688389) 2024 Quarterly Report Review: Outstanding International Business Performance, Rapid IVD Growth
Matters: The company released its 2024 quarterly report, with revenue of 306 million yuan (+10.06%), net profit to mother of 107 million yuan (+21.69%), net profit after deducting non-net profit of 103 million yuan (+24.60 million yuan)
Tianfeng Securities released a research report on April 26 stating that it gave Pumen Technology (688389.SH) a buying rating. The main reasons for the rating include: 1) growth in all business segments, and growth in domestic and overseas markets; 2) buil
Tianfeng Securities released a research report on April 26 stating that it gave Pumen Technology (688389.SH) a buying rating. The main reasons for the rating include: 1) growth in all business segments, and growth in domestic and overseas markets; 2) building new brands and deepening internationalization; 3) striving for excellence in the field of in vitro diagnosis, and repeated introduction of new products in the field of treatment and rehabilitation. (Mainichi Keizai Shimbun)
No Data